ESC 365 - Summary and close.

Open Access

Summary and close.

Session: Heart failure: what is the potential of SGLT2 inhibition?

Topic: Chronic heart failure

Speaker: Doctor S. Williams (Manchester, GB)

Sponsored by AstraZeneca

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Simon Williams

Manchester (United Kingdom of Great Britain & Northern Ireland)

5 presentations

0 follower

5 more presentations in this session

Welcome and introduction.

Speaker: Doctor S. Williams (Manchester, GB) Doctor J. Day (Luton, GB)

The ongoing problem of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)

The ongoing problem of heart failure - Q&A.

Speaker: Professor J. McMurray (Glasgow, GB) Doctor S. Williams (Manchester, GB)

SGLT2 inhibition: the potential to change the heart failure landscape?

Speaker: Doctor M. Kosiborod (Kansas City, US)

SGLT2 inhibition: the potential to change the heart failure landscape? Q&A.

Access the full session

Heart failure: what is the potential of SGLT2 inhibition?

Speakers: Doctor S. Williams, Doctor S. Williams, Doctor J. Day, Professor J. McMurray, Professor J. McMurray...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources